Yuting Cao - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yuting Cao

Showing results (161-170 of 165) with videos related to

Pageof 17

Sort By:

You have reached the last page of results.This site can display upto 165 results.

European Journal of Medicinal Chemistry|December 1, 2020

First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivoMingming Wei, Rui Zhao, Yuting Cao, et al.

Theranostics|January 3, 2023

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatmentRongjuan Wang, Chang Zhang, Yuting Cao, et al.

ACS Applied Materials & Interfaces|December 29, 2022

Biomimetic, pH-Responsive Nanoplatforms for Cancer Multimodal Imaging and Photothermal ImmunotherapyLi Wan, Yuting Cao, Chen Cheng, et al.

European Journal of Medicinal Chemistry|July 18, 2020

Design and synthesis of Leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injuryXiaohe Li, Maodun Xie, Cheng Lu, et al.

Biorxiv : the Preprint Server for Biology|January 7, 2026

Tuning the open-close equilibrium of Cereblon with small molecules influences protein degradationSuzanne O'Connor, Zoe J Rutter, Angus D Cowan, et al.

Pageof 17

Search research articles

Showing results (161-170 of 165) with videos related to

Sort By:

Pageof 17

You have reached the last page of results.This site can display upto 165 results.

European Journal of Medicinal Chemistry|December 1, 2020

First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivoMingming Wei, Rui Zhao, Yuting Cao, et al.

Theranostics|January 3, 2023

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatmentRongjuan Wang, Chang Zhang, Yuting Cao, et al.

ACS Applied Materials & Interfaces|December 29, 2022

Biomimetic, pH-Responsive Nanoplatforms for Cancer Multimodal Imaging and Photothermal ImmunotherapyLi Wan, Yuting Cao, Chen Cheng, et al.

European Journal of Medicinal Chemistry|July 18, 2020

Design and synthesis of Leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injuryXiaohe Li, Maodun Xie, Cheng Lu, et al.

Biorxiv : the Preprint Server for Biology|January 7, 2026

Tuning the open-close equilibrium of Cereblon with small molecules influences protein degradationSuzanne O'Connor, Zoe J Rutter, Angus D Cowan, et al.

Pageof 17